Skip to main content
. 2017 Dec 15;9(12):5558–5566.

Figure 3.

Figure 3

Metformin attenuates neovascularization in the development of DR through suppressing VEGF-A. (A, B) Vessel density was analyzed at 12 weeks after alloxan, shown by representative images (A), and by quantification (B). (C) ELISA for VEGF-A protein in mouse eyes. (D) RT-qPCR for VEGF-A RNA in mouse eyes. *P<0.05. NS: non-significant. N=10.